Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: The EPICURE randomised clinical trial

EuroIntervention

Volumn 13, Issue 1, 2017, Pages 44-52

  Urena, Marina ^a   Del Trigo, Maria ^a   Altisent, Omar Abdul Jawad ^a   Campelo Prada, Francisco ^a   Regueiro, Ander ^a   DeLarochellière, Robert ^a   Doyle, Daniel ^a   Mohammadi, Siamak ^a   Paradis, Jean Michel ^a   Dagenais, François ^a   Dumont, Eric ^a   Puri, Rishi ^a   Laroche, Vincent ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Adjunctive pharmacotherapy; Miscellaneous; Transcatheter aortic valve implantation (TAVI)

Indexed keywords

HEMOGLOBIN; IRON SACCHARATE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; TROPONIN; EPO PROTEIN, HUMAN; ERYTHROPOIETIN; IRON;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ANEMIA; AORTIC VALVE STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERSENSITIVITY; HYPERTENSION; INFECTIOUS COMPLICATION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; TREATMENT INDICATION; METABOLISM; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; ERYTHROPOIETIN; FEMALE; HUMANS; IRON; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 85019956192     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJ-D-16-00591     Document Type: Article

References (35)

1. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544-52.
2. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, Moehnle P, Mangano DT; Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007;116:471-9.
3. Nikolsky E, Mehran R, Sadeghi HM, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Fahy M, Lansky AJ, Stone GW. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device investigation to Lower Late Angioplasty Complications) Trial. JACC Cardiovasc Interv. 2009;2:624-32.
4. Nuis RJ, Sinning JM, Rodés-Cabau J, Gotzmann M, van Garsse L, Kefer J, Bosmans J, Yong G, Dager AE, Revilla- Orodea A, Urena M, Nickenig G, Werner N, Maessen J, Astarci P, Perez S, Benitez LM, Amat-Santos IJ, Lopez J, Dumont E, van Mieghem N, van Gelder T, van Domburg RT, de Jaegere PP. Prevalence, factors associated with, and prognostic effects of preoperative anemia on short- and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2013;6:625-34.
5. Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth. 2008;11:15-9.
6. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Shore- Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford- Smith M, Waters J; International Consortium for Evidence Based Perfusion, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944-82.
7. Sowade O, Warnke H, Scigalla P, Sowade B, Franke W, Messinger D, Gross J. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood. 1997;89:411-8.
8. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929-37.
9. Kiyama H, Ohshima N, Imazeki T, Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg. 1999;68:1652-6.
10. Weltert L, D'Alessandro S, Nardella S, Girola F, Bellisario A, Maselli D, De Paulis R. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg. 2010;139:621-6.
11. Yazicioglu L, Eryilmaz S, Sirlak M, Inan MB, Aral A, Tasoz R, Eren NT, Kaya B, Akalin H. Recombinant human erythropoietin administration in cardiac surgery. J Thorac Cardiovasc Surg. 2001;122:741-5.
12. Hayashi J, Kumon K, Takanashi S, Kawashima Y, Eguchi S, Takaku F, Yamamura H. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion. 1994;34:142-6.
13. Walpoth B, Galliker B, Spirig P, Haeberli A, Rosenmund A, Althaus U, Nydegger UE. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol. 1996;33:75-6.
14. Watanabe Y, Fuse K, Naruse Y, Kobayashi T, Yamamoto S, Konishi H, Horii T, Shibata Y. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg. 1992;54:479-83.
15. Weltert L, Rondinelli B, Bello R, Falco M, Bellisario A, Maselli D, Turani F, De Paulis R, Pierelli L. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion. 2015;55:1644-54.
16. Alghamdi AA, Albanna MJ, Guru V, Brister SJ. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg. 2006;21:320-6.
17. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-Operative Transfusion (ISPOT) Investigators. Transfus Med. 1998;8:309-17.
18. Cladellas M, Farré N, Comin-Colet J, Gomez M, Merono O, Bosch MA, Vila J, Molera R, Segovia A, Bruguera J. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol. 2012;110:1021-6.
19. Van Mieghem NM, Nuis RJ, Tzikas A, Piazza N, Schultz C, Serruys PW, de Jaegere PP. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention. 2011;7:184-91.
20. Escarcega RO, Lipinski MJ, Magalhaes MA, Baker NC, Minha S, Okubagzi PG, Torguson R, Chen F, Ben-Dor I, Satler LF, Pichard AD, Waksman R. Impact of blood transfusions on short-and long-term mortality in patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2015;115:93-9.
21. DeLarochellière H, Urena M, Amat-Santos IJ, Ribeiro HB, Allende R, Laflamme L, Laflamme J, Paradis JM, Dumont E, Doyle D, Mohammadi S, DeLarochellière R, Côté M, Laroche V, Rodés-Cabau J. Effect on outcomes and exercise performance of anemia in patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015;115:472-9.
22. Seiffert M, Conradi L, Terstesse AC, Koschyk D, Schirmer J, Schnabel RB, Wilde S, Ojeda FM, Reichenspurner H, Blankenberg S, Schäfer U, Treede H, Diemert P. Blood transfusion is associated with impaired outcome after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015;85:460-7.
23. Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol. 2011;9:15-29.
24. Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60:1438-54.
25. Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics. 1978;34:483-6.
26. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med. 1997;336:933-8.
27. van der Putten K, Braam B, Jie KE, Gaillard CA. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. Nat Clin Pract Nephrol. 2008;4:47-57.
28. Gabrilove J. Anemia and the elderly: clinical considerations. Best Pract Res Clin Haematol. 2005;18:417-22.
29. van der Meer P, van Veldhuisen DJ. Anaemia and renal dysfunction in chronic heart failure. Heart. 2009;95:1808-12.
30. Brugnara C, Chambers L, Malynn E, Goldberg M, Kruskall M. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood. 1993;81:956-64.
31. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Am J Surg. 1995;170:37S-43S.
32. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-98.
33. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-8.
34. Monk TG. Preoperative recombinant human erythropoietin in anemic surgical patients. Crit Care. 2004;8 Suppl 2:S45-8.
35. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA; Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med. 2010;363:1146-55.